Vaccination targeting human HER3 alters the phenotype of infiltrating T cells and responses to immune checkpoint inhibition

Expression of human epidermal growth factor family member 3 (HER3), a critical heterodimerization partner with EGFR and HER2, promotes more aggressive biology in breast and other epithelial malignancies. As such, inhibiting HER3 could have broad applicability to the treatment of EGFR- and HER2-drive...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncoimmunology
Autors principals: Osada, Takuya, Morse, Michael A., Hobeika, Amy, Diniz, Marcio A., Gwin, William R., Hartman, Zachary, Wei, Junping, Guo, Hongtao, Yang, Xiao-Yi, Liu, Cong-Xiao, Kaneko, Kensuke, Broadwater, Gloria, Lyerly, H. Kim
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2017
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5486174/
https://ncbi.nlm.nih.gov/pubmed/28680745
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2017.1315495
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars